Skip to content

Eton Pharmaceutical

US · ETON #2944 by market cap Listed 2018
60.85 -0.51 -0.83%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 60.54 -1.34%
After-hours 60.85 0.00%
Overnight 61.96 +0.98%
68.4027.4060.852026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ETON?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +137.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 6.9% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 39.5x Better than 14%
Forward P/E 21.8x Better than 32%
Price / Sales 13.1x Better than 8%
P/E vs own 5-yr range 85th pctl Better than 22%
Growth A+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 55.5% Better than 96%
Free cash flow CAGR (3Y) 71.1% Better than 89%
Profitability C-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 53.5% Better than 67%
Operating margin -1.1% Better than 20%
Net margin -5.8% Better than 19%
Return on equity -18.2% Better than 17%
Return on invested capital -7.6% Better than 19%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -4.1% Better than 64%
6-month return 86.7% Better than 99%
12-month return (ex latest month) 203.9% Better than 99%
Distance below 52-week high 13.9% Better than 75%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 43%
Debt to assets 33.7% Better than 35%
Analyst View B+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 32.7% Better than 52%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -4.82%
1M +21.24%
3M +1.57%
6M +76.63%
YTD +259.85%
1Y +273.31%
3Y +1,663.77%
5Y +1,234.43%

Key statistics

Price & volume

Prev close
61.36
Open
61.00
Day range
59.18 - 61.65
Avg price
60.64
Volume
562.66K
Turnover
34.12M
Amplitude
4.03%
52-week range
14.27 - 70.64

Valuation

P/E
-357.94
P/E (TTM)
39.51
P/B
20.19
EPS
-0.17
Net profit
-4.90M
Net assets
86.93M

Share structure

Market cap
1.76B
Float cap
1.37B
Shares out
28.84M
Float shares
22.52M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2018-11-09
52-week range 83% of range
14.27 70.64

13.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+3.22M net over the window

Short interest

Shares short
1.99M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Eton Pharmaceutical (ETON)?

Eton Pharmaceutical last traded at 60.85. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Eton Pharmaceutical's market cap?

About 1.76B.

What is the P/E ratio of Eton Pharmaceutical?

The trailing twelve-month P/E is 39.51. The Valuation tab shows it against the stock's own five-year range.

Does Eton Pharmaceutical pay a dividend?

Eton Pharmaceutical does not currently pay a regular dividend.

Is Eton Pharmaceutical a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 80.75, which implies 32.7% upside from the current price. This is not investment advice.

What is Eton Pharmaceutical's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Eton Pharmaceutical a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

Eton Pharmaceutical discussion 0 comments

Add a comment